Accessibility Menu
Doximity logo

Doximity(NYSE) DOCS

Market Cap$3.76BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-61%
5 Year-66%
1 Year-64%
1 Month-3%
$21.77
+4.09%
+0.86Today
After hours$21.66-$0.10 (-0.48%)
Doximity last closing stock price
MetricPriceDate
Last closeUSD 20.912026-07-31
Doximity stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.4%USD 20.422026-07-24
1 month-3.15%USD 21.592026-07-01
3 month-16.29%USD 24.982026-05-01
Year to date-52.78%USD 44.282025-12-31
1 year-64.41%USD 58.752025-07-31
3 year-39.9%USD 34.792023-08-01
5 year-66.22%USD 61.902021-07-30
Since inception-60.55%USD 53.002021-06-24

Doximity Financials at a Glance

Market Cap

$3.76BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$644.86M

Net Income (TTM)

$196.05M

EPS (TTM)

$0.98

P/E Ratio

21.31

Dividend

$0.00

Beta (Volatility)

1.41 (Average)

Price

$21.77

Volume

2,947,555.827

Open

$21.32

Previous Close

$21.66

Daily Range

$21.27 - $21.99

52-Week Range

$17.15 - $76.51

Estimated Earnings Date

Aug 6, 2026

DOCS: Motley Fool Moneyball Superscore

64

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Doximity

Doximity helps doctors and medical professionals talk to each other and care for patients online. The company makes tools for mobile phones and computers that simplify paperwork and medical scheduling. These digital services help pharmaceutical firms and hospitals reach healthcare experts across the United States.

What Doximity Builds

  • Marketing Solutions: Digital tools that let pharmaceutical companies and health systems share medical news and research with specific healthcare professionals.
  • Hiring Solutions: A professional database that helps medical recruiters find, message, and hire doctors or other clinical staff.
  • Workflow Solutions: Software for secure voice and video patient calls, digital faxing, and AI-driven writing help for clinical notes.

Recent Strategic Moves

  • Acquired Pathway Medical on July 29, 2025, to add artificial intelligence tools and new engineering talent to the platform.
  • Authorized a new program on February 3, 2026, to buy back up to $500 million of its own Class A common stock.
  • Purchased and retired over 8.6 million shares for $417 million under a previous buyback plan as of December 31, 2025.
  • Integrated an artificial intelligence writing assistant into the platform to help clinicians with administrative tasks and decision support.

What Makes the Platform Unique

Doximity operates as a specialized social network exclusively for the medical community, combining professional networking with clinical productivity tools. Its platform serves a dual purpose by helping doctors manage their daily work while providing a verified channel for healthcare companies to reach them.

The Financial Scorecard

  • Revenue grew to $185.1 million in Q3 2026, an increase of 9.8% from the previous year.
  • Net income was $61.6 million in Q3 2026, down 18.1% from $75.2 million in Q3 2025.
  • Free cash flow reached $62.9 million in Q3 2026, a slight decrease of 0.9% year-over-year.
  • Gross profit for the third quarter of 2026 was $166.4 million, representing a 7.7% increase from 2025.
  • Operating income hit $71.9 million in Q3 2026, down 10% from $79.9 million in the prior year period.

Bottom Line

Doximity has transitioned from a basic networking site into a multi-functional digital hub for the American medical workforce. By adding artificial intelligence and telehealth tools, the company has deepened its role in both clinical workflows and pharmaceutical marketing.

AI Generated • Apr 23, 2026

Industry

Health Care Technology

Employees

880

CEO

Jeffrey A. Tangney, MBA

Headquarters

San Francisco, CA 94107, US

DOCS Financials

Key Financial Metrics (TTM)

Gross Margin

89.09%

Operating Margin

33.33%

Net Income Margin

30.40%

Return on Equity

19.36%

Return on Capital

22.36%

Return on Assets

17.45%

Earnings Yield

4.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.76BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

179.75M

Volume

2.95M

Avg. Volume

4.06M

Financials (TTM)

Gross Profit

$574.54M

Operating Income

$214.92M

EBITDA

$266.09M

Operating Cash Flow

$326.46M

Capital Expenditure

-$8.96M

Free Cash Flow

$317.50M

Cash & ST Invst.

$748.60M

Total Debt

$10.19M

Doximity Performance Analysis

Doximity annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 419,052,00022.0%
20242024-03-31USD 475,422,00013.5%
20252025-03-31USD 570,399,00020.0%
20262026-03-31USD 644,863,00013.1%
Doximity sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-305.5%
Q22025-09-3015.5%
Q32025-12-319.8%
Q42026-03-31-21.4%
Doximity annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD 0.53-24.1%
20242024-03-31USD 0.7235.7%
20252025-03-31USD 1.1154.6%
20262026-03-31USD 0.98-11.2%
Doximity sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-12.9%
Q22025-09-3014.8%
Q32025-12-31N/A
Q42026-03-31-67.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$145.37M

+5.1%

Gross Profit

$125.97M

+1.7%

Gross Margin

86.65%

N/A

Market Cap

$3.76BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.27M

N/A

Employees

880

N/A

Net Income

$19.11M

-69.4%

EBITDA

$36.25M

-40.8%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

$748.60M

-18.2%

Total Debt

$10.19M

-17.8%

Accounts Receivable

$144.78M

+12.8%

Inventory

$0.00

N/A

Long Term Debt

$8.07M

-20.7%

Short Term Debt

$2.11M

-4.6%

Return on Assets

17.45%

N/A

Return on Invested Capital

22.19%

N/A

Free Cash Flow

$107.27M

+10.6%

Operating Cash Flow

$109.52M

+11.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TEMTempus AI, Inc.
$46.05+4.97%
HQYHealthEquity, Inc.
$104.36+3.73%
EHCEncompass Health Corporation
$112.47+1.26%
ICLRICON Public Limited Company
$158.41-3.15%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.05%
NVDANvidia
$206.64+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81+0.07%
INTCIntel
$91.00+0.01%

Questions About DOCS

What is the current price of Doximity?

Doximity is trading at $21.66 per share.

What is the 52-week range for Doximity?

Over the past 52 weeks, Doximity has traded between $17.15 and $76.51.

How much debt does Doximity have?

As of the most recent reporting period, Doximity reported total debt of $10.19M.

How much cash does Doximity have on hand?

Doximity reported $219.18M in cash and cash equivalents in its most recent financial results.

What is Doximity’s dividend yield?

Doximity does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.